Medicines and Related Products (Amendment) Act, 2023
Medicines and Related Products (Amendment) Act, 2023 is the official MCA identifier for “Medicines and Related Products (Amendment) Act, 2023”. Medicines and Related Products (Amendment) Act, 2023 is the official identifier MCA uses for this instrument.
- Instrument
- Medicines
- Full name
- Medicines and Related Products (Amendment) Act, 2023
- Category
- General
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Medicines and Related Products (Amendment) Act, 2023
Complete four-page enacted amendment supplied by the National Assembly, passed 21 September 2023. Inserts section 26(5)–(6), permitting a mechanism other than registration for products manufactured or produced in recognised reference countries and requiring Gazette publication of the reference-country list. This 2023 text is distinct from the additional 2025 amendment referred to by the current 2026 listing guideline; that later original remains to be acquired.
Medicines and Related Products (Amendment) Act, 2023 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.